• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

News/Conferences

Final results of from the EURAS-IUD extension study

Posted: 2018-01-11

Our latest publication, Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study, has just been published in the European Journal of Contraception and Reproductive Health Care.  This landmark observational study followed women for 5 years and identified intra-uterine device (IUD) perforations dectected from 12 to 60 months following IUD insertion.

The incidence of uterine perforations in this study was low, although higher than the commonly reported rate.  Clinical sequalae of perforations were generally mild and associated with a very low risk of injury.  You can download the full text of article using this link: Full Article

 

Filed Under: Publications

Meet us at ICPE

Posted: 2017-08-07

We are delighted to be packing our bags again this summer and heading across the Atlantic to the International Society of Pharmacoepidemiology (ISPE) conference in Montreal, Canada.  Our project management team will be presenting five posters and one oral presentation over the five days sharing the latest developments from our non-interventional, primary data driven studies.

33rd ICPE

We will also be sharing a booth with our friends and colleagues at Kantar Health.  If you miss us during one of our sessions, come and find us in the exhibit hall.

 

Filed Under: Conferences

Join us at the 33rd International Conference on Pharmacoepidemiology and Clinical research

Posted: 2016-12-24

Join ZEG Berlin at the 33rd International Conference on Pharmacoepidemiology and Clinical research in August, 2017.

We will have oral and poster presentations on our latest studies. Last year ZEG presented two oral presentations and three poster presentations. This year is set to be no different.

Filed Under: Conferences

Fertility and oral contraceptives

Posted: 2016-02-04

Our latest publication, Fertility and combined oral contraceptives – unintended pregnancies and planned pregnancies following oral contraceptive use – results from the INAS-SCORE study, was published in the European Journal of Contraception and Reproductive Health in October 2016. In this article we reviewed the secondary fertility outcomes from the INAS-SCORE study and compared United States and European data. Interestingly, even after excluding ‘improper use’ as a cause for unplanned pregnancy, US women were more likely to expereince unplanned pregnancies than their European counterparts – a result we still cannot explain.

Interested in accessing the full article? The first 50 readers can access the full article using this link.

Filed Under: News

  • « Go to Previous Page
  • Page 1
  • Page 2

sidebar

Library & News

  • News/Conferences
  • Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.